Joel P. Cooper

A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation

Jennifer L. Oberfield, Jon L. Collins, Christopher P. Holmes et al. · Proceedings of the National Academy of Sciences · 1999 · 318 citations

Medicine, Medicinal Chemistry, Pharmacology +16

<i>N</i>-(2-Benzoylphenyl)-<scp>l</scp>-tyrosine PPARγ Agonists. 3. Structure−Activity Relationship and Optimization of the <i>N</i>-Aryl Substituent

Jeff E. Cobb, Steven G. Blanchard, Evan G. Boswell et al. · Journal of Medicinal Chemistry · 1998 · 111 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Peptide and Peptide Mimetic Inhibitors of Antigen Presentation by HLA-DR Class II MHC Molecules. Design, Structure−Activity Relationships, and X-ray Crystal Structures

David Bolin, Amy L. Swain, Ramakanth Sarabu et al. · Journal of Medicinal Chemistry · 2000 · 91 citations

Pharmacy, Immunology, Medicinal Chemistry +17

Highly selective heterogeneous palladium-catalyzed hydrogenations using triethoxysilane and water

James M. Tour, Joel P. Cooper, Shekhar L. Pendalwar · The Journal of Organic Chemistry · 1990 · 50 citations

Natural Sciences, Chemistry, Catalysis +8

The discovery and optimization of pyrimidinone-containing MCH R1 antagonists

Donald L. Hertzog, Kamal Albarazanji, Eric C. Bigham et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 47 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12